Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,940.00p

Change Today:

-4.00p
52 Week High: 1,998.00
52 Week Low: 1,060.00

Currency: UK Pounds
Shares Issued: 136.24m
Volume: 128,556

Market Cap: £2,643.06m
RiskGrade: 314
Beta: 0.00

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

1 Day Chart (07-02-2023)

6 Month Chart

More Indivior charts

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

	Latest	F'cast
Div Yield	0.0%	0.0%
Div Cover	n/a	n/a
Op Mrgn	26.9%	12.0%
ROCE	44.9%

	Latest	F'cast
P/E	24.5	1764.7
PEG	0.2	n/a
Pr/Revenue	4.0	2.9
Pr/Book	15.6

	Latest	F'cast
Revenue	22.3%	-5.7%
PBT	n/a	-52.7%
EPS	137.5%	-98.6%
DPS	n/a	n/a

Indivior Fundamentals

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-17	1,093.00	137.00	185.00¢	13.3	2.2	+6%	n/a	0.0%
31-Dec-18	1,005.00	278.00	185.00¢	3.7	n/a	n/a	n/a	0.0%
31-Dec-19	785.00	180.00	120.00¢	2.0	n/a	-35%	n/a	0.0%
31-Dec-20	647.00	(173.00)	40.00¢	16.4	n/a	-67%	n/a	0.0%
31-Dec-21	791.00	190.00	95.00¢	16.3	0.1	+138%	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Indivior Forecasts

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-22	898.71	108.24	1.10p	1,764.7	n/a	-99%	n/a	0.0%
31-Dec-23	955.81	127.97	1.18p	1,650.6	0.1	+7%	n/a	0.0%
31-Dec-24	1,103.68	135.91	1.91p	1,016.0	0.0	+62%	n/a	0.0%

Indivior forecasts

Indivior Company Announcements

Transaction in Own Shares	07-Feb-2023	07:00	RNS
HSR Period for Opiant Acquisition Expires	06-Feb-2023	13:00	RNS
Transaction in Own Shares	06-Feb-2023	07:00	RNS

More indivior company announcements

Indivior ShareCast News

Indivior raises guidance for peak net revenue po...	07-Dec-2022	ShareCast
Indivior to buy US overdose treatment firm Opian...	14-Nov-2022	ShareCast
Indivior ups FY guidance after solid third quarter	27-Oct-2022	ShareCast

More Indivior ShareCast news

Latest Indivior Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

Indivior Market Data

Currency	UK Pounds
Share Price	1,940.00p
Change Today	-4.00p
% Change	-0.21 %
52 Week High	1,998.00
52 Week Low	1,060.00
Volume	128,556
Shares Issued	136.24m
Market Cap	£2,643.06m
Beta	0.00
RiskGrade	314